Key Considerations to Identify and Work with Transparent, High-Quality, Cost-Effective PBMs
“Manufacturer rebates to PBMs increased nearly 225% ($50B) in four years, and are often used to steer patients to more expensive and less effective drugs.”
Source: Pew Charitable Trust, 2019
How can employers and benefit purchasers avoid this? Learn more in this buyer’s guide.
- A value-driven, transparent partnership with PBMs, benefits consultants, and TPAs
- A thorough reporting process to comply with the CAA and help meet fiduciary obligations
- A clean, simple, and concise employer-PBM agreement that meets fiduciary standards
- A partnership with a PBM that does not use “spread pricing,” passes rebates to employers, charges one administrative fee, guarantees savings, and has robust reporting capabilities.
1Evernoth Book of Business 2021